Titel

Merkliste
1 Ergebnisse

A randomised study of rituximab and belimumab sequential th..:

McClure, Mark E ; Gopaluni, Seerapani ; Wason, James...
https://discovery.ucl.ac.uk/id/eprint/10168383/1/A%20randomised%20study%20of%20rituximab%20and%20belimumab%20sequential%20therapy%20in%20PR3%20ANCA-associated%20vasculitis%20%28COMBIVAS%29%20design%20of%20the%20.pdf. , 2023

Link: https://discovery.ucl.ac.uk/id/eprint/10168383/1/A%20r..

RT Journal
T1 <Title>A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:10168383&Exemplar=1&LAN=DE
				
A1 McClure, Mark E
A1 Gopaluni, Seerapani
A1 Wason, James
A1 Henderson, Robert B
A1 Van Maurik, Andre
A1 Savage, Caroline CO
A1 Pusey, Charles D
A1 Salama, Alan D
A1 Lyons, Paul A
A1 Lee, Jacinta
A1 Mynard, Kim
A1 Jayne, David R
A1 Jones, Rachel B
A1 COMBIVAS, Investigators
PB BMC
YR 2023
K1 Science & Technology
K1 Life Sciences & Biomedicine
K1 Medicine
K1 Research & Experimental
K1 Research & Experimental Medicine
K1 ANCA
K1 Vasculitis
K1 Rituximab
K1 Belimumab
K1 WEGENERS-GRANULOMATOSIS
K1 EFFICACY
K1 ANTIBODY
K1 BAFF
JF https://discovery.ucl.ac.uk/id/eprint/10168383/1/A%20randomised%20study%20of%20rituximab%20and%20belimumab%20sequential%20therapy%20in%20PR3%20ANCA-associated%20vasculitis%20%28COMBIVAS%29%20design%20of%20the%20.pdf
LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/10168383/1/A%20randomised%20study%20of%20rituximab%20and%20belimumab%20sequential%20therapy%20in%20PR3%20ANCA-associated%20vasculitis%20%28COMBIVAS%29%20design%20of%20the%20.pdf
DO https://discovery.ucl.ac.uk/id/eprint/10168383/1/A%20randomised%20study%20of%20rituximab%20and%20belimumab%20sequential%20therapy%20in%20PR3%20ANCA-associated%20vasculitis%20%28COMBIVAS%29%20design%20of%20the%20.pdf
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)